Status:
TERMINATED
New York Blood Center National Cord Blood Program
Lead Sponsor:
New York Blood Center
Conditions:
Leukemia
Lymphoma
Eligibility:
All Genders
Phase:
EARLY_PHASE1
Brief Summary
Umbilical cord blood is used as a source of hematopoietic stem cells for bone marrow reconstitution in patients who would be potential candidates for a bone marrow transplant from an unrelated marrow ...
Detailed Description
Umbilical cord blood donated to the New York Blood Center's National Cord Blood Program is collect, tested, processed, cryoprotected and frozen in liquid nitrogen for possible future transplantation t...
Eligibility Criteria
Inclusion
- Candidates for bone marrow transplantation
Exclusion
- \-
Key Trial Info
Start Date :
February 1 1993
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2011
Estimated Enrollment :
4476 Patients enrolled
Trial Details
Trial ID
NCT00212407
Start Date
February 1 1993
End Date
November 10 2011
Last Update
November 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Blood Center
New York, New York, United States, 10021